Literature DB >> 24789465

Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy.

Pablo Hernández-Martínez1, Rosa Dolz-Marco, Marta Alonso-Plasencia, Rodrigo Abreu-Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24789465     DOI： 10.1007/s00417-014-2634-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  10 in total

1.  Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.

Authors:  J Fernando Arevalo; Alfredo Adan; Maria H Berrocal; Juan V Espinoza; Mauricio Maia; Lihteh Wu; Jose A Roca; Hugo Quiroz-Mercado; Jose M Ruiz-Moreno; Martin A Serrano
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

2.  Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.

Authors:  Nishant Kumar; Marcela Marsiglia; Sarah Mrejen; Adrian Tien-Chin Fung; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

3.  Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome.

Authors:  Yannis Perentes; T Van Tran; Michel Sickenberg; Carl P Herbort
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

4.  Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.

Authors:  Alexander Rouvas; Petros Petrou; Maria Douvali; Amalia Ntouraki; Ioannis Vergados; Ilias Georgalas; Nikolaos Markomichelakis
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

5.  Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.

Authors:  Ahmad M Mansour; J Fernando Arevalo; Christine Fardeau; Emily N Hrisomalos; Wai-Man Chan; Timothy Y Y Lai; Focke Ziemssen; Thomas Ness; Abla Mehio Sibai; Friederike Mackensen; Armin Wolf; Nicholas Hrisomalos; Arnd Heiligenhaus; Georg Spital; Yukari Jo; Fumi Gomi; Yasushi Ikuno; Jad Akesbi; Phuc LeHoang; Alfredo Adan; Padmamalini Mahendradas; Moncef Khairallah; Rainer Guthoff; Blanche Ghandour; Cem Küçükerdönmez; Shree K Kurup
Journal:  Can J Ophthalmol       Date:  2012-06       Impact factor: 1.882

6.  Risk of choroidal neovascularization among the uveitides.

Authors:  Sally L Baxter; Maxwell Pistilli; Siddharth S Pujari; Teresa L Liesegang; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; John H Kempen
Journal:  Am J Ophthalmol       Date:  2013-06-21       Impact factor: 5.258

7.  Inflammatory choroidal neovascularization.

Authors:  Piergiorgi Neri; Marta Lettieri; Cinzia Fortuna; Mara Manoni; Alfonso Giovannini
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

8.  Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

Authors:  Thi Ha Chau Tran; Christine Fardeau; Céline Terrada; Ghislaine Ducos De Lahitte; Bahram Bodaghi; Phuc Lehoang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

Review 9.  An update on the pharmacotherapy of neovascular age-related macular degeneration.

Authors:  K Bailey Freund; Sarah Mrejen; Roberto Gallego-Pinazo
Journal:  Expert Opin Pharmacother       Date:  2013-04-08       Impact factor: 3.889

10.  Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.

Authors:  Ahmad M Mansour; Friederike Mackensen; Padmamalini Mahendradas; Moncef Khairallah; Timothy Yy Lai; Ziad Bashshur
Journal:  Clin Ophthalmol       Date:  2012-08-01
  10 in total
  4 in total

1.  [Statement from the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular degeneration : October 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

Review 2.  New Immunosuppressive Therapies in Uveitis Treatment.

Authors:  Salvador Mérida; Elena Palacios; Amparo Navea; Francisco Bosch-Morell
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

Review 3.  Inflammatory Choroidal Neovascular Membranes in Patients With Noninfectious Uveitis: The Place of Intravitreal Anti-VEGF Therapy.

Authors:  Omer Karti; Sefik Can Ipek; Yesim Ates; Ali Osman Saatci
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2020-03-25

4.  Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization.

Authors:  Sourour Zina; Sana Khochtali; Alessandro Invernizzi; Imen Ksiaa; Ben Amor Hager; Francesco Viola; Nesrine Abroug; Moncef Khairallah
Journal:  J Curr Ophthalmol       Date:  2021-03-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.